Skip to content

Candida albicans IgA ELISA kit-SERION classic ESR117A

$398.00

Summary

  • Virion/Serion Diagnostic Kit for research use (RUO)
  • Candida albicans IgA ELISA Kit
  • Suitable for IgA detection
  • Ready-to-use
  • 96 tests
SKU: ESR117A Category: Tags: , ,
Weight 1 lbs
Dimensions 9 × 5 × 2 in
target

Candida albicans reactive IgA

species reactivity

Candida albicans

applications

ELISA

assay type

Indirect & quantitative

available sizes

96 tests

Candida albicans IgA ELISA Kit ESR117A

kit
Assay type
Indirect ELISA
Research area
Infectious Disease
Sample type
Serum, plasma, whole blood
Components
Break apart microtiter test strips each with antigen coated single wells 8 x 12 (96 Total)
Standard serum (ready-to-use)2 x 2 mL
Negative control serum (ready-to-use)2 mL
Anti-human-IgA-conjugate (ready-to-use)13 mL
Washing solution concentrate (sufficient for 1000ml)33.3 mL
Dilution buffer2 x 50 mL
Stopping solution15 mL
Substrate (ready-to-use)13 mL
Quality control certificate with standard curve and evaluation table1
Storage
Store at 2-8°C.
Associated products
Candida albicans Antigen (BA117VS)
Candida Antigen Assay Control (BC200)
Candida albicans IgA Control Serum (BC117A)
Candida albicans IgG Control Serum (BC117G)
Candida albicans IgM Control Serum (BC117M)
Candida albicans IgA ELISA Kit (ESR117A)
Candida albicans IgG ELISA Kit (ESR117G)
Candida albicans IgM ELISA Kit (ESR117M)
Candida Antigen Detection ELISA Kit (ESR200)
target relevance
Candida albicans
Description
Fungus that causes candidiasis and opportunistic fungal infections
Structure
Candida albicans is a dimorphic yeast-like fungus belonging to the family Debaryomycetaceae and is the most common cause of human candidiasis. The organism normally colonizes the oral cavity, gastrointestinal tract, genitourinary tract, and skin of healthy individuals as part of the normal microbiota. Candida albicans exhibits remarkable morphological flexibility and can transition between yeast, pseudohyphal, and true hyphal forms depending on environmental conditions. This ability to undergo morphologic switching is an important virulence factor that facilitates tissue invasion, immune evasion, and biofilm formation. C. albicans is an opportunistic pathogen that typically causes disease when host defenses are compromised, microbiota balance is disrupted, or anatomical barriers are breached. It is one of the most common fungal pathogens responsible for both superficial mucosal infections and invasive systemic disease.
Diagnosis
The diagnosis of Candida albicans infection is performed through microbiological, microscopic, molecular, and serological methods. Direct microscopic examination of clinical specimens using potassium hydroxide preparations, Gram staining, or fungal stains may reveal budding yeast cells, pseudohyphae, and hyphae. Culture on fungal media remains a standard diagnostic method and allows species identification and antifungal susceptibility testing. Molecular techniques such as polymerase chain reaction (PCR) provide rapid and sensitive detection of Candida DNA. In cases of invasive candidiasis, blood cultures, beta-D-glucan assays, antigen detection tests, and advanced molecular diagnostics may assist in diagnosis. Histopathological examination of affected tissues can demonstrate fungal invasion and support the diagnosis of invasive disease.
Symptoms
Candida albicans infections range from mild superficial disease to life-threatening systemic infections. Oral candidiasis (thrush) commonly presents with white plaques on the tongue and oral mucosa, soreness, and difficulty swallowing. Vulvovaginal candidiasis is characterized by itching, irritation, redness, burning, and abnormal vaginal discharge. Cutaneous candidiasis may cause erythematous, moist, and pruritic lesions, particularly in warm skin folds. Invasive candidiasis occurs when the organism enters the bloodstream or deep tissues and may present with persistent fever, chills, sepsis, organ dysfunction, and failure to respond to antibacterial therapy. Patients at highest risk include immunocompromised individuals, transplant recipients, cancer patients, premature infants, and critically ill hospitalized patients. Untreated invasive infection may disseminate to the kidneys, liver, spleen, heart, eyes, brain, and other organs, resulting in significant morbidity and mortality.

Data

FAQ & Publications

Frequently Asked Questions
What sample types are compatible with the Candida albicans IgA ELISA Kit ESR117A?
The Candida albicans IgA ELISA Kit ESR117A is compatible with serum, plasma, and whole blood samples for detecting Candida albicans reactive IgA.
How should the Candida albicans IgA ELISA Kit ESR117A be stored to maintain its stability?
The kit should be stored at 2-8°C to preserve the components and ensure optimal assay performance.
Publications
pmid title authors citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
ESR117A protocol

Documents

#
Please enter your product and batch number here.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.